Skip to main content

Table 1 Clinical and biological characteristics of HCC and liver metastasis patients

From: Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection

 

HCC (n = 94)

Liver metastasis (n = 14)

Age, yearsa

69 (65–87)

60 (21–85)

Gender (male/female)

70/24

10/4

Plt (×103/μl)a

14.2 (3.1–34.6)

27.8 (81–195)

BMI (kg/m2)a

21.5 (18.5–33.5)

21.7 (19.0–27.5)

Alb (g/dl)a

4.1 (2.8–5.1)

4.4 (3.4–4.8)

T-Bil (mg/dl)a

0.7 (0.3–2.9)

0.8 (0.5–2.1)

AST (U/L)a

36.5 (13–114)

19 (14–62)

ALT (U/L)a

30.9 (9–114)

16 (10–61)

M2BPGi (COI))a

2.79 (0.29–8.75)

0.55 (0.29–3.89)

FIB-4 indexa

4.27 (0.3–13.7)

2.14 (0.34–1.42)

SVR/non-SVR

30/64

–

Fibrosis (F:0–1/2/3/4)

(2/36/39/17)

(14/0/0/0)

Inflammation (A:0/1/2/3)

(0/17/60/17)

(14/0/0/0)

FibroScan (kPa)a

13.9 (2.5–46.4)

5.1 (2.5–8.3)

VTQ (m/s)a

1.79 (0.89–3.45)

1.23 (0.96–1.47)

HCC Stage (I/II/III)

(48/35/11)

–

  1. amedian (range)
  2. Plt platelet count, BMI Body Mass Index, Alb albumin, T-Bil total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, M2BPGi Mac-2 binding protein glycosylation isomer, SVR sustained viral response, VTQ Virtual-Touch tissue quantification, HCC hepatocellular carcinoma